An instructive case of amlodipine-induced reversible granulomatous CD30+ T-cell pseudolymphoma

Australas J Dermatol. 2020 Aug;61(3):e346-e350. doi: 10.1111/ajd.13240. Epub 2020 Jan 22.

Abstract

We report an unusual case of drug-associated granulomatous CD30+ T-cell pseudolymphoma secondary to amlodipine. A 55-year-old Chinese man presented with a 6-month eruption of disseminated erythematous dermal papulonodules and annular infiltrated plaques over his neck and limbs symmetrically. Histopathology revealed a perivascular and interstitial infiltrate of histiocytes, eosinophils and morphologically normal lymphocytes associated with CD30 expression. The eruption improved rapidly after discontinuation of amlodipine and did not recur.

Keywords: CD30+ lymphoproliferative disorder; amlodipine; cutaneous T cell lymphoma; drug-associated reversible granulomatous T-cell dyscrasia; drug-induced pseudolymphoma; eosinophilia; interstitial granulomatous drug reaction; mycosis fungoides.

Publication types

  • Case Reports

MeSH terms

  • Amlodipine / adverse effects*
  • Antihypertensive Agents / adverse effects*
  • Drug Eruptions / etiology
  • Granuloma / chemically induced*
  • Granuloma / pathology
  • Humans
  • Ki-1 Antigen / metabolism
  • Male
  • Middle Aged
  • Pseudolymphoma / chemically induced*
  • Pseudolymphoma / pathology
  • T-Lymphocytes / metabolism

Substances

  • Antihypertensive Agents
  • Ki-1 Antigen
  • Amlodipine